These medicines are used to treat type 2 diabetes or obesity, with the common risk of gastrointestinal side effects which may affect more than 1 in 10 patients. While most…
A Statutory Instrument (SI) laid in Parliament today, 21 October, will provide a new regulatory framework meaning that medicines with a very short shelf life and highly personalised medicines can…
Patients and the public rely on the Medicines and Healthcare products Regulatory Agency (MHRA) to ensure that all medical products used in the UK meet the necessary standards of safety,…
#MedSafetyWeek forms part of international efforts to raise awareness about the importance of reporting suspected side effects to national medicines regulatory authorities such as the Medicines and Healthcare products Regulatory…
